cis-Dichlorodiammineplatinum (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum (II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung

J. C. Britell, R. T. Eagan, J. N. Ingle, E. T. Creagen, J. Rubin, S. Frytak

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'cis-Dichlorodiammineplatinum (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum (II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung'. Together they form a unique fingerprint.

Medicine & Life Sciences